Trial intelligence / Profile preview

Envarsus XR vs IR Tacrolimus in Kidney Transplant Recipients

NCT03437577Phase 2Completed

Sponsor
University of Minnesota
Start
May 2018
Primary completion
Mar 2020
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tacrolimus in kidney transplant rejection, sponsored by University of Minnesota. Started May 2018; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT03437577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03437577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call